CC
HALO icon

Centiva Capital’s Halozyme HALO Stock Holding History

Centiva Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,369
Closed -$435K – 1404
2025
Q2 		$435K Buy
8,369
+5,033
+151% +$286K 0.01% 1026
2025
Q1 		$213K Sell
3,336
-10,114
-75% -$588K 0.01% 1262
2024
Q4 		$643K Buy
+13,450
New +$690K 0.01% 686
2024
Q3 		– Sell
-8,884
Closed -$465K – 2335
2024
Q2 		$465K Buy
+8,884
New +$390K 0.01% 1199
2023
Q3 		– Sell
-5,902
Closed -$213K – 1852
2023
Q2 		$213K Buy
+5,902
New +$201K ﹤0.01% 1310
2023
Q1 		– Sell
-6,929
Closed -$394K – 1649
2022
Q4 		$394K Buy
+6,929
New +$355K 0.01% 850
2021
Q3 		– Sell
-8,701
Closed -$395K – 1418
2021
Q2 		$395K Buy
+8,701
New +$385K 0.01% 920
2019
Q4 		– Sell
-11,930
Closed -$185K – 863
2019
Q3 		$185K Buy
+11,930
New +$197K 0.01% 519

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Centiva Capital's HALO Position: Q3 2025 in Review

Centiva Capital sold out of Halozyme (HALO) in Q3 2025, closing a stake of 8,369 shares — an estimated $435K sold.

Centiva Capital first reported a position in HALO in Q3 2019 and held it in 8 quarters. The position peaked at $643K in Q4 2024. 603 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Centiva Capital reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 8,369 Halozyme shares in Q3 2025, an estimated $435K.
  • Centiva Capital first reported a position in Halozyme in Q3 2019 and held it in 8 quarters.
  • Centiva Capital's Halozyme position peaked at $643K in Q4 2024.
  • 603 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.